Document ID: chunk:federal_register_of_legislation:F2021L01163:reg:9:p3
Version: federal_register_of_legislation:F2021L01163
Segment Type: reg
Provision Reference: reg 9 (pt 3/6)
Character Range: 9366–12383

of fibrosing interstitial lung disease;
(17)      having acute respiratory distress syndrome within the 6 months before the clinical onset of fibrosing interstitial lung disease;
Note: acute respiratory distress syndrome is defined in the Schedule 1 - Dictionary.
(18)      being treated with a cytotoxic agent for a malignant neoplasm or in association with haematopoietic stem cell transplantation, before the clinical onset of fibrosing interstitial lung disease;
(19)      taking a drug from the specified list of drugs within the 6 months before the clinical onset of fibrosing interstitial lung disease;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(20)      having chronic or recurrent diffuse alveolar haemorrhage before the clinical onset of fibrosing interstitial lung disease;
Note: diffuse alveolar haemorrhage is defined in the Schedule 1 - Dictionary.
(21)      having exogenous lipoid pneumonitis at the time of the clinical onset of fibrosing interstitial lung disease;
Note: exogenous lipoid pneumonitis is defined in the Schedule 1 - Dictionary.
(22)      having tropical pulmonary eosinophilia for at least the 6 months before the clinical onset of fibrosing interstitial lung disease;
Note: tropical pulmonary eosinophilia is defined in the Schedule 1 - Dictionary.
(23)      inhaling a vapour, gas, dust or fumes produced by a substance from the specified list of substances, or smoke from fire, in an enclosed space:
(a)          for a cumulative period of at least 5,000 hours before the clinical onset of fibrosing interstitial lung disease; and
(b)          if that exposure has ceased before the clinical onset of fibrosing interstitial lung disease, then that onset occurred within 20 years of cessation;
Note: specified list of substances is defined in the Schedule 1 - Dictionary.
(24)      inhaling a vapour, gas, dust or fumes produced by a substance from the specified list of substances, or smoke from fire, in an open environment:
(a)          for a cumulative period of at least 10,000 hours before the clinical onset of fibrosing interstitial lung disease; and
(b)          if that exposure has ceased before the clinical onset of fibrosing interstitial lung disease, then that onset occurred within 20 years of cessation;
Note: specified list of substances is defined in the Schedule 1 - Dictionary.
(25)      having smoked tobacco products:
(a)          in an amount of at least 10 pack-years before the clinical worsening of fibrosing interstitial lung disease; and
(b)          commencing at least 1 year before the clinical worsening of fibrosing interstitial lung disease;
Note: one pack-year is defined in the Schedule 1 - Dictionary.
(26)      inhaling respirable asbestos fibres at the time material containing asbestos was being applied, removed, cut, drilled, dislodged or disturbed:
(a)          for a cumulative period of at least 1,500 hours before the clinical worsening of fibrosing interstitial lung disease; and
(b)          within the